Turkish Pharmaceutical Company Abdi İbrahim is on Metaverse

The Turkish pharmaceutical company, Abdi İbrahim, is making significant strides in the global pharmaceutical industry.

Building on the success of its NFT collection, the company has once again innovated by venturing into the Metaverse with a blockchain-based structure.

This move solidifies Abdi İbrahim’s commitment to pioneering advancements and embracing cutting-edge technologies in the pharmaceutical sector.


Abdi İbrahim on Metaverse

The Turkish pharmaceutical company Abdi İbrahim continues to pioneer advancements in the global pharmaceutical industry. Following the success of its NFT collection, the company has now entered the Metaverse by establishing a building on blockchain in Decentraland, one of the most popular Metaverse platforms.

Located on parcel 120-4 within Decentraland, Abdi İbrahim’s innovative structure showcases ‘The Journey of Healing’ NFT collection. This collection features the artistic works of collage artist Selman Hoşgör and is prominently displayed on one floor of the blockchain-based building. This move underscores Abdi İbrahim’s commitment to embracing emerging technologies and creating a presence in the dynamic realm of the Metaverse.


Designed with inspiration from the headquarters building

Abdi İbrahim’s presence in the Metaverse was meticulously designed using a special technique, drawing inspiration from the architectural aesthetics of its headquarters in Maslak, Istanbul. Beyond its symbolic representation, Abdi İbrahim plans to utilize this virtual structure for hosting in-house events in the near future.

As part of its “HEAL2030” sustainability strategy, Abdi İbrahim has embarked on its digitalization journey, marking a significant milestone with “The Journey of Healing” NFT collection. This initiative solidifies Abdi İbrahim’s position as a trailblazer in the Turkish pharmaceutical industry, actively preparing for the future shaped by decentralized metaverses, Web 3.0, and blockchain technologies. The company remains committed to its innovative endeavors, positioning itself at the forefront of the evolving landscape of healthcare and technology.


You may also like this content

Exit mobile version